(Q30363877)

20 June 2017

Summary of knowledge gaps related to quality and efficacy of current influenza vaccines. (English)

1 reference

20 June 2017

knowledge gap hypothesis

1 reference

1 reference

Michael Pfleiderer

1

1 reference

20 June 2017

Jean-Hugues Trouvin

2

1 reference

20 June 2017

Daniel Brasseur

3

1 reference

20 June 2017

Marta Gränstrom

4

1 reference

20 June 2017

Ragini Shivji

5

1 reference

20 June 2017

Manuela Mura

6

1 reference

20 June 2017

Marco Cavaleri

7

1 reference

20 June 2017

language of work or name

English

0 references

publication date

20 June 2014

1 reference

20 June 2017

1 reference

20 June 2017

32

1 reference

20 June 2017

35

1 reference

20 June 2017

4586-4591

1 reference

New influenza vaccines: promises, perils, and pitfalls

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

On the relationship between mean antibody level, seroprotection and clinical protection from influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

T cell responses are better correlates of vaccine protection in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

Complex correlates of protection after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.027

10.1016/J.VACCINE.2014.05.027

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference